Article and Video CATEGORIES
ASCO 2022 Head and Neck Cancer
In this video series Dr. Kathryn Gold, Medical Oncologist specializing in lung, head, and neck cancers, Professor, Department of Medicine, UC San Diego, and Dr. Siddharth Sheth, Medical oncologist, Assistant Professor of Medicine, Division of Medical Oncology, UNC Chapel Hill, discuss the newest updates in head and neck cancer, presented at ASCO 2022.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…